| Literature DB >> 30767889 |
Mariem Rouatbi1, Safa Amairia1, Yosra Amdouni1, Mohamed Anis Boussaadoun1, Ouarda Ayadi2, Amira Adel Taha Al-Hosary3, Mourad Rekik4, Rym Ben Abdallah5, Karim Aoun5, Mohamed Aziz Darghouth1, Barbara Wieland6, Mohamed Gharbi1.
Abstract
Toxoplasmosis is an important zoonosis caused by an obligate intracellular parasitic protozoan, Toxoplasma gondii. The disease is distributed worldwide and can affect all warm-blooded vertebrates, including humans. The present review aimed to collect, compile and summarize the data on the prevalence of T. gondii infection in humans and animals in the five North African countries (Morocco, Algeria, Tunisia, Libya and Egypt). Published data from national and international databases were used. Distribution patterns and risk factors for T. gondii infection are discussed, focusing on biotic and abiotic factors. This review is a comprehensive epidemiological analysis of T. gondii infection in North Africa and will therefore be a useful tool for researchers. It can also be used to propose or enhance appropriate national toxoplasmosis control programs. © Rouatbi et al., published by EDP Sciences, 2019.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30767889 PMCID: PMC6376878 DOI: 10.1051/parasite/2019006
Source DB: PubMed Journal: Parasite ISSN: 1252-607X Impact factor: 3.000
Characteristics of North African countries.
| Country | Capital city | Area (km2) | Sahara surface (km2) | Population (2017) | Density (inhabitants/km2 in 2017) | Percentage of total world population (%) | Percentage urban population (2017) (%) | Median age (years) |
|---|---|---|---|---|---|---|---|---|
| Morocco | Rabat | 446,300 | – | 35,913,182 | 80 | 0.47 | 59.6 | 28.3 |
| Algeria | Algiers | 2,381,740 | 2,000,000 | 41,582,461 | 17 | 0.55 | 73 | 27.8 |
| Tunisia | Tunis | 155,360 | 90,000 | 11,580,938 | 74 | 0.15 | 66.9 | 31.4 |
| Libya | Tripoli | 1,759,540 | 700,000 | 6,411,555 | 4 | 0.08 | 80.3 | 27.6 |
| Egypt | Cairo | 995,450 | 3,000,000 | 98,250,741 | 98 | 1.29 | 38.8 | 24.8 |
Source: Worldmeters [127].
Livestock indicators in North Africa, 2014.
| Country | Livestock/TLU (2013) | Livestock as share of gross value of agricultural production (constant 2004-2006 US$) | Total meat production (1000 tonnes) |
|---|---|---|---|
| Morocco | 4,897,310 | 40% | 1,077 |
| Algeria | 4,829002 | 35% | 681 |
| Tunisia | 1,499,680 | 24% | 320 |
| Libya | 1,176,450 | NA | 176 |
| Egypt | 7,527,000 | 43% | 1,810 |
Source: These data were compiled from different sources [58].
TLU: Tropical Livestock Units.
NA: Not Available.
Wild felid species present in North Africa.
| Species | Description | Geographic distribution | Reference |
|---|---|---|---|
| Caracal | Body length: 61–105 cm | Mauritania, Morocco, | [ |
|
| Height: 40–50 cm | Algeria, Tunisia, Libya, | |
| Weight: 8–20 kg | Egypt | ||
| In captivity, average lifespan as long as 16 years | |||
| Chaus | Relatively short tail, long legs, big | Morocco, Algeria, Egypt | [ |
|
| pointed ears | ||
| Sand cat | Weight: 2–3 kg | Morocco, Algeria, | [ |
|
| Living in arid areas with temperatures ranging from 0 °C to 58 °C | Tunisia, Libya, Egypt | |
| Serval | Medium sized African cats | Morocco, Algeria, Tunisia | [ |
|
| Body length: approximately 60 cm | ||
| Weight: on average 14 kg | |||
| Average life in the wild is 10 years | |||
| African wildcat | Body length: 40–66 cm | Morocco, Algeria, | |
|
| Tail length: 24–37 cm | Tunisia, Libya, Egypt | |
| Weight: 2.4–6.4 kg |
Estimated domestic herbivore population in North Africa (1000 heads).
| Country | Sheep | Goats | Cattle | Camels | Equines |
|---|---|---|---|---|---|
| Morocco | 17,078 | 5118 | 2814 | 70 | NA |
| Algeria | 20,000 | 3800 | 1650 | 290 | 218 |
| Tunisia | 7616 | 1550 | 1400 | 200 | 187 |
| Libya | 4500 | 1265 | 130 | 47 | NA |
| Egypt | 2258 | 1054 | 2810 | 68 | 1072 |
| Overall | 60,302 | 18,387 | 10,494 | 2275 | NA |
NA: Not Available.
Source: OIE [97] and FAO [57].
Human toxoplasmosis prevalence in North African countries.
| Country (author) | Region | Population/sample | Technique | Positive/examined (%) | Reference |
|---|---|---|---|---|---|
| Morocco (Le Viguelloux and Epardeau, 1969) | – | Patients | IFAT | 100/154 (64.9) | [ |
| Morocco (Nejmi and Alami, 1973) | Rabat | Military personnel, schoolgirls and pregnant women | IFAT | 281/1026 (27.4) | [ |
| Morocco (Biava et al., 1983) | Marrakech | Women | IFAT/Hemagglutination | 106/318 (33.3) | [ |
| Morocco (Guessous-Idrissi et al., 1984) | – | Women | – | −(51.5) | [ |
| Morocco (El Mansouri et al., 2007) | Kenitra | Pregnant women | ELISA | −(36.7) | [ |
| Morocco (El Mansouri et al., 2007) | Nador | Pregnant women | ELISA | −(43.3) | [ |
| Morocco (El Mansouri et al., 2007) | Tetouan | Pregnant women | ELISA | −(42.6) | [ |
| Morocco (El Mansouri et al., 2007) | Rabat | Pregnant women | ELISA | 1242/2456 (50.6) | [ |
| Morocco (Laboudi et al., 2009) | Rabat | Pregnant women | ELISA | 516/1020(50.6) | [ |
| Morocco (Barkat et al., 2010) | Rabat | Pregnant women | – | 163/368 (44.3) | [ |
| Morocco (Addebbous et al., 2012) | Marrakesh | HIV-infected adults | Indirect ELISA | 59/95 (62.1) | [ |
| Morocco (Laboudi et al., 2014) | Rabat | Pregnant women | ELISA | 549/1169 (47) | [ |
| Morocco (Laboudi, 2017) | Rabat | Pregnant women | ELISA | 59/128 (46.1) | [ |
| Morocco (Tlamcani et al., 2017) | Fes | Pregnant women | CMIA | 1367/3440 (39.7) | [ |
| Algeria (Balozet, 1955) | Algiers | Humans | CFT | 13/125 (10.4) | [ |
| Algeria (Schneider et al., 1977) | Algiers | Patients | IFAT | 1297/2438 (53.2) | [ |
| Algeria (Messserer et al., 2014) | Annaba | Pregnant women | Microparticle enzyme | 491/1028 (47.8) | [ |
| Algeria (Berredjem et al., 2017) | Annaba | Pregnant women | ELISA | 57/143 (39.9) | [ |
| Algeria (Berredjem et al., 2017) | Annaba | Pregnant women | PCR | 9/57 (15.8) | [ |
| Algeria (Berredjem et al., 2017) | Annaba | Pregnant women | PCR (P30 gene) | 4/14 (28.6) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Blind children | SFDT | 19/92 (20.6) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Adolescents | SFDT | 18/30 (60) | [ |
| Tunisia (Messedi-Triki et al., 1982) | Tunis | – | – | 402/810 (49.6) | [ |
| Tunisia (Jemni et al., 1985) | Sousse | Students | – | −(67) | [ |
| Tunisia (Bchir et al., 1992) | Monastir | Pregnant women | ELISA | 195/478 (40.8) | [ |
| Tunisia (Ben Ayed Nouira et al., 1994) | Tunis | Women | – | −(63.5) | [ |
| Tunisia (Bouratbine et al., 2001) | Beja | Individuals | ELISA and IFAT | 830/1421 (58.4) | [ |
| Tunisia (Sellami et al., 2010) | Sfax | Pregnant women | ELISA | 15952/40567 (39.3) | [ |
| Tunisia (Ben Abdallah et al., 2013) | Tunis | Pregnant women | ELISA | 944/2070 (45.6) | [ |
| Tunisia (Fakhfakh et al., 2013) | Tunis | Pregnant women | Immunocapture | 1114/2351 (47.4) | [ |
| Tunisia (Siala et al., 2014) | Tunis | Amniotic fluid | PCR | 12/60 (20) | [ |
| Libya (Khadre and Nageh, 1987) | Tripoli | Adult males | – | 1032/2000 (51.6) | [ |
| Libya (Khadre and Nageh, 1987) | Tripoli | Adult females | – | 130/300 (43.3) | [ |
| Libya (Khadre and Nageh, 1987) | Tripoli | Schoolchildren | – | 865/1980 (43.7) | [ |
| Libya (Khadre and Nageh, 1987) | Tripoli | Female patients with abortion history | – | 1334/1921 (69.4) | [ |
| Libya (Kassem and Morsy, 1991) | Benghazi | Pregnant women | IHAT | 176/369 (47.7) | [ |
| Libya (Elsaid et al., 2014) | Tripoli | Control volunteers | ELISA | 3/300 (1) | [ |
| Libya (Elsaid et al., 2014) | Tripoli | Psychiatric patients | ELISA | 151/300 (50.3) | [ |
| Libya (Elsaid et al., 2014) | Tripoli | Control volunteers | Latex | 140/300 (46.7) | [ |
| Libya (Elsaid et al., 2014) | Tripoli | Psychiatric patients | Latex | 185/300 (61.7) | [ |
| Libya (Gamal and Jaroud, 2015) | Alkhoms | Pregnant women | ELISA | 142/361 (39.3) | [ |
| Libya (Shalaka et al., 2015) | Tripoli | Patients with HIV/AIDS | – | 19/227 (8.4) | [ |
| Libya (Gashout et al., 2016) | Tripoli | Women who have had spontaneous abortions | ELISA | 54/140 (38.6) | [ |
| Libya (Gashout et al., 2016) | Tripoli | HIV patients | ELISA | 23/26 (88.5) | [ |
| Libya (Gashout et al., 2016) | Sabrata | Patients with leukemia or lymphoma | ELISA | 6/9 (66.7) | [ |
| Libya (Gashout et al., 2016) | Zawia | Children with ocular infection | ELISA | 1/2 (50) | [ |
| Libya (Haq et al., 2016) | Misurata | Pregnant women | PCR | 27/276 (9.8) | [ |
| Egypt (Azab et al., 1992) | – | Serum of lactating women | IFAT | 22/70 (31.4) | [ |
| Egypt (Azab et al., 1992) | – | Milk of lactating women | IFAT | 12/70 (17.1) | [ |
| Egypt (Youssef, 1993) | Dakahlia | Inhabitants | Dot-ELISA | −(23.8) | [ |
| Egypt (Ibrahim et al., 1997) | Gharbia | Workers | IHAT | 11/21 (52.4) | [ |
| Egypt (Ibrahim et al., 1997) | Dakahlia | Pregnant women | ELISA | 52/101 (51.5) | [ |
| Egypt (Amrei et al., 1999) | Zagazig | Children with intellectual disability | – | 14/32 (43.7) | [ |
| Egypt (Amrei et al., 1999) | Zagazig | Adult females | – | −(37.5) | [ |
| Egypt (Elsheikha et al., 2009) | Mansoura | Blood donors | ELISA | 155/260 (59.6) | [ |
| Egypt (El-Gozamy et al., 2009) | Qualyobia | Pregnant women | ELISA | 46.5 to 57.6 | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Pregnant women | ELISA IgG | 27/59 (45.8) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Pregnant women | ELISA IgM | 18/59 (30.5) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Pregnant women | SFDT | 14/ 59 (23.7) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Pregnant women | PCR | 19/59 (33.2) | [ |
| Egypt (El Deeb et al., 2012) | Menoufia | Pregnant women | ELFA | 218/323 (67.5) | [ |
| Egypt (Ahmed et al., 2014) | Sharkia | Pregnant women | MAT | 82/100 (82) | [ |
| Egypt (Kamal et al., 2015) | Minia | Women with high risk pregnancy | ELISA | 61/120 (50.8) | [ |
| Egypt (Ibrahim et al., 2017) | Menoufia | Pregnant women | ELISA | 63/171 (36.8) | [ |
| Egypt (Ibrahim et al., 2017) | Menoufia | Pregnant women | RT-PCR | 24/171 (14) | [ |
| Egypt (Ibrahim et al., 2017) | Gharbia | Pregnant women | ELISA | 60/193 (31.1) | [ |
| Egypt (Ibrahim et al., 2017) | Gharbia | Pregnant women | RT-PCR | 19/193 (9.8) | [ |
IFAT: ImmunoFluorescent Antibody Test.
ELISA: Enzyme Linked Immunosorbent Assay.
CMIA: Chemiluminescent Microparticle Immunoassay
CFT: Complement-Fixation Test.
PCR: Polymerase Chain Reaction.
SFDT: Sabin-Feldman Dye Test.
IHAT: Indirect Hemagglutination Antibody test.
ELFA: Enzyme-Linked Fluorescence Assay.
MAT: Modified Agglutination Test.
RT-PCR: Real-Time Polymerase Chain Reaction.
– : Not Available.
Figure 1Prevalence of Toxoplasma gondii infection in Morocco: Animal toxoplasmosis, seroprevalence.
Animal toxoplasmosis prevalence in North African countries.
| Country (author) | Region | Population/sample | Technique | Positive/examined (%) | Reference |
|---|---|---|---|---|---|
| Morocco (Benkirane et al., 1990) | Rabat | Sheep | ELISA | −(30) | [ |
| Morocco (Belbacha et al., 2004) | Marrakech | Sheep | ELISA | 15/50 (30) | [ |
| Morocco (Sawadogo et al., 2005) | Marrakech | Sheep | ELISA | 72/261 (27.6) | [ |
| Morocco (Benkirane et al., 2015) | Northern Morocco and Middle Atlas | Sheep | ELISA | 42/202 (20.8) | [ |
| Morocco (Benkirane et al., 2015) | Northern Morocco and Middle Atlas | Goats | ELISA | 9/106 (8.5) | [ |
| Algeria (Balozet, 1955) | Algiers | Dogs | CFT | 32/105 (30.5) | [ |
| Algeria (Dechicha et al., 2015) | Blida | Cattle | IFAT | 13/332 (3.9) | [ |
| Algeria (Dechicha et al., 2015) | Djelfa | Sheep | IFAT | 32/276 (11.6) | [ |
| Algeria (Dechicha et al., 2015) | Djelfa | Goats | IFAT | 14/106 (13.2) | [ |
| Algeria (Abdelhadi et al., 2015) | Tiaret | Cattle | ELISA | 14/92 (15.2) | [ |
| Algeria (Mohamed–Cherif et al., 2015) | Tiaret | Horses | MAT | 76/293 (25.9) | [ |
| Algeria (Mohamed–Cherif et al., 2015) | Tiaret | Donkeys | MAT | 9/30 (30) | [ |
| Algeria (Yekkour et al., 2017) | Algiers | Stray cats | MAT | 48/96 (50) | [ |
| Algeria (Dahmani et al., 2018) | Western, Eastern and South | Sheep | ELISA | 48/580 (8.3) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Sheep | SFDT | 169/225 (75.1) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Goats | SFDT | 51/85 (60) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Cattle | SFDT | 93/250 (37.2) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Cattle | SFDT | 16/100 (16) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Camels | SFDT | 48/120 (40) | [ |
| Tunisia (Ben Rachid and Blaha, 1970) | – | Dogs | SFDT | 142/200 (71) | [ |
| Tunisia (Boughattas et al., 2011) | Sidi Thabet, Monastir and Battan | Horses | MAT | 28/158 (17.7) | [ |
| Tunisia (Gharbi et al., 2013) | Ben Arous | Sheep | PCR | 9/71 (12.7) | [ |
| Tunisia (Gharbi et al., 2013) | Kasserine | Sheep | ELISA | 35/184 (19) | [ |
| Tunisia (Gharbi et al., 2013) | Sidi Bouzid | Sheep | PCR | 27/106 (25.5) | [ |
| Tunisia (Gharbi et al., 2013) | Siliana | Sheep | ELISA | 3/166 (1.8) | [ |
| Tunisia (Khayeche et al., 2013) | Sousse | Sheep | PCR | 4/70 (5.7) | [ |
| Tunisia (Boughattas et al., 2014) | Tunis | Young sheep | MAT | 83/217 (38.2) | [ |
| Tunisia (Boughattas et al., 2014) | Tunis | Adult sheep | MAT | 92/125 (73.6) | [ |
| Tunisia (Lahmar et al., 2015) | Gafsa | Sheep | MAT | 82/204 (40.2) | [ |
| Tunisia (Lahmar et al., 2015) | Gafsa | Goats | MAT | 11/32 (34.4) | [ |
| Tunisia (Lahmar et al., 2015) | Gafsa | Cattle | MAT | 3/25 (12) | [ |
| Tunisia (Amairia et al., 2016) | Tabarka | Goats | ELISA | 17/34 (50) | [ |
| Tunisia (Amairia et al., 2016) | Hammam Bourghiba | Goats | ELISA | 7/43 (16.3) | [ |
| Tunisia (Amairia et al., 2016) | Tabarka | Goats’ milk | PCR | 0/34 | [ |
| Tunisia (Amairia et al., 2016) | Hammam Bourghiba | Goats’ milk | PCR | 6/43 (13.9) | [ |
| Tunisia (Rouatbi et al., 2017) | Beja | Sheep | PCR | 48/150 (32) | [ |
| Tunisia (Rouatbi et al., 2017) | Sidi Bouzid | Sheep | PCR | 54/174 (31) | [ |
| Tunisia (Amdouni et al., 2017) | Beja | Sheep | PCR | 50/150 (33.3) | [ |
| Tunisia (Amdouni et al., 2017) | Beja | Cattle | PCR | 29/150 (19.3) | [ |
| Tunisia (Amdouni et al., 2017) | Beja | Goats | PCR | 39/120 (32.5) | [ |
| Libya (Azwai et al., 1993) | – | Goats | IHAT | −(50) | [ |
| Libya (Azwai et al., 1993) | – | Sheep | IHAT | −(26.2) | [ |
| Libya (Azwai et al., 1993) | – | Horses | IHAT | −(4.8) | [ |
| Libya (Azwai et al., 1993) | An-Najila | Cattle | IHAT | −(27.4) | [ |
| Libya (Azwai et al., 1993) | Khadra’ | Cattle | IHAT | −(14.3) | [ |
| Libya (Azwai et al., 1993) | Al Hany | Cattle | IHAT | −(10.6) | [ |
| Libya (El-Gomati et al., 2010) | Tripoli | Mice | Toxocell latex test | 21/60 (35) | [ |
| Libya (Al-mabruk et al., 2013) | Western, Central, Eastern and Southern | Sheep | LAT | 4122/5806 (71) | [ |
| Egypt (Rifaat et al., 1976) | Cairo | Chickens | DT | 17/85 (20) | [ |
| Egypt (Rifaat et al., 1976) | Cairo | Rabbits | DT | 49/100 (49) | [ |
| Egypt (Ibrahim et al., 1997) | Tanta | Sheep | IHAT | 114/258 (44.2) | [ |
| Egypt (Ibrahim et al., 1997) | Tanta | Sheep | IFAT | 126/258 (48.8) | [ |
| Egypt (Hilali et al., 1998) | – | Camels | DAT | 29/166 (17.5) | [ |
| Egypt (El-Ghaysh, 1998) | Monofia | Donkeys | ELISA | 79/121 (65.3) | [ |
| Egypt (Dubey et al., 2003) | Giza | Free range chickens | MAT | 49/121 (40.5) | [ |
| Egypt (Ghazy et al., 2007) | – | Horses | ELISA | 160/420 (38.1) | [ |
| Egypt (Shaapan et al., 2008) | Cairo | Sheep | MAT | 131/300 (43.7) | [ |
| Egypt (Shaapan et al., 2008) | Cairo | Sheep | ELISA | 125/300 (41.7) | [ |
| Egypt (Shaapan et al., 2008) | Cairo | Sheep | IFAT | 111/300 (37) | [ |
| Egypt (Shaapan et al., 2008) | Cairo | Sheep | DT | 102/300 (34) | [ |
| Egypt (Ibrahim et al., 2009) | Sharkia | Cattle | ELISA | 10/93 (10.7) | [ |
| Egypt (Haridy et al., 2010) | Cairo | Working donkeys | ELISA | 45/100 (45) | [ |
| Egypt (Haridy et al., 2010) | Cairo | Donkeys’ milk | ELISA | 7/15 (46.7) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Sheep | ELISA | 61/62 (98.4) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Sheep | PCR | 42/62 (67.7) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Goats | ELISA | 10/24 (41.7) | [ |
| Egypt (Ghoneim et al., 2010) | El Fayoum | Goats | PCR | 6/24 (25) | [ |
| Egypt (Harfoush and Tahoon, 2010) | Kafr El-Sheikh | Domestic ducks | IHAT | −(55) | [ |
| Egypt (Harfoush and Tahoon, 2010) | Kafr El-Sheikh | Free-range chickens | IHAT | −(38.1) | [ |
| Egypt (Harfoush and Tahoon, 2010) | Kafr El-Sheikh | Turkeys | IHAT | −(29.4) | [ |
| Egypt (Ashmawy et al., 2011; Harfoush and Tahoon, 2010) | Kafr El-Sheikh | Domestic rabbits | IHAT | −(17.5 to 37.5) | [ |
| Egypt (Al-Kappany et al., 2011) | Cairo | Feral cats | MAT | 172/180 (95.5) | [ |
| Egypt (Ashmawy et al., 2011) | Alexandria | Domestic rabbits | IHAT | 9/85 (10.6) | [ |
| Egypt (Ashmawy et al., 2011) | Behera | Domestic rabbits | IHAT | 6/69 (8.7) | [ |
| Egypt (Barakat et al., 2012) | Cairo | Chickens | ELISA | −(62.2) | [ |
| Egypt (Barakat et al., 2012) | Gharbia | Chickens | ELISA | −(82.3) | [ |
| Egypt (Barakat et al., 2012) | Kafr El sheikh | Chickens | ELISA | −(67.1) | [ |
| Egypt (Barakat et al., 2012) | Quena | Chickens | ELISA | −(75) | [ |
| Egypt (Barakat et al., 2012) | Sharkia | Chickens | ELISA | −(59.5) | [ |
| Egypt (Barakat et al., 2012) | Sohag | Chickens | ELISA | −(50) | [ |
| Egypt (Behairy et al., 2013) | Giza | Turkeys | MAT | 103/173 (59.5) | [ |
| Egypt (Behairy et al., 2013) | Giza | Chickens | MAT | 51/108 (47.2) | [ |
| Egypt (Behairy et al., 2013) | Giza | Ducks | MAT | 24/48 (50) | [ |
| Egypt (El-Madawy and Metawea, 2013) | Ismailia | Ostriches | ELISA | 15/120 (12.5) | [ |
| Egypt (El-Madawy and Metawea, 2013) | Ismailia | Ostriches | PCR | 9/120 (7.5) | [ |
| Egypt (Behairy et al., 2013) | Giza | Dogs | MAT | 50/51 (98) | [ |
| Egypt (Behairy et al., 2013) | Giza | Hearts of dogs | Bioassay | 22/43 (51.2) | [ |
| Egypt (Ahmed et al., 2014) | Sharkia | Sheeps’ milk | PCR | 1/50 (2) | [ |
| Egypt (Ahmed et al., 2014) | Sharkia | Goats’ milk | PCR | 4/50 (8) | [ |
| Egypt (Ahmed et al., 2014) | Sharkia | Cows’ milk | PCR | 0/50 | [ |
| Egypt (Mahmoud et al., 2015) | Gharbia | Stray cats | IHAT | 17/92 (18.5) | [ |
| Egypt (Mahmoud et al., 2015) | Gharbia | Stray cats | IFAT | 19/92 (20.7) | [ |
| Egypt (Mahmoud et al., 2015) | Gharbia | Owned cats | IHAT | 4/32 (12.5) | [ |
| Egypt (Mahmoud et al., 2015) | Gharbia | Owned cats | IFAT | 5/32 (15.6) | [ |
| Egypt (Ibrahim et al., 2017) | Menoufia | Sheep | ELISA | −(51.04) | [ |
| Egypt (Ibrahim et al., 2017) | Menoufia | Sheep | RT-PCR | −(17.71) | [ |
| Egypt (Ibrahim et al., 2017) | Gharbia | Sheep | ELISA | −(52.70) | [ |
| Egypt (Ibrahim et al., 2017) | Gharbia | Sheep | RT-PCR | −(17.57) | [ |
LAT: Latex Agglutination Test.
DT: Dye Test.
DAT: Direct Agglutination Test.
Figure 2Prevalence of Toxoplasma gondii infection in Algeria: Animal toxoplasmosis, seroprevalence.
Figure 3Prevalence of Toxoplasma gondii infection in Tunisia: Animal toxoplasmosis, seroprevalence.
Figure 4Prevalence of Toxoplasma gondii infection in Tunisia: Animal toxoplasmosis, molecular prevalence.
Figure 5Prevalence of Toxoplasma gondii infection in Libya: Animal toxoplasmosis seroprevalence.
Figure 6Prevalence of Toxoplasma gondii infection in Egypt: Animal toxoplasmosis, seroprevalence.
Figure 7Prevalence of Toxoplasma gondii infection in Egypt: Animal toxoplasmosis, molecular prevalence.
Figure 8Overall status of Toxoplasma gondii seroprevalence in humans in North African countries: (A) Minimum infection rates; (B) Maximum infection rates.
Figure 9Overall number of studies dealing with human and animal toxoplasmosis in five North African countries (Morocco, Algeria, Tunisia, Libya and Egypt).
Figure 10Distribution of studies dealing with human and animal toxoplasmosis in five North African countries over time (Morocco, Algeria, Tunisia, Libya and Egypt).